HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nonprofit Pharmaceutical Companies

496.856

-9.219-1.82%

Number of Gainers:5

Number of Losers:25

Number of Flat:3

PE:- -

High:517.538

Open:506.335

Low:496.695

Close:506.075

Volume:48.91M

Turnover:1.47B

Market Cap:317.31B

Float Cap:282.74B

Loading ...

HBM's Cancer Drug Candidate Gets China Approval

MT Newswires Live

Alphamab's KN026 Combination Therapy for First-Line HER2-Positive Advanced Breast Cancer Receives NMPA Filing Acceptance

Suzhou Basecare Medical Sets Board Meeting to Review Interim Results, Consider Dividend

Alphamab Oncology Says China NMPA Accepts Anbenitamab NDA for First-Line HER2+ Advanced Breast Cancer

Alphamab Oncology - Nmpa Accepts Nda for Anbenitamab (Kn026) with Hb1801 for Her2+ Advanced Breast Cancer

THOMSON REUTERS

Edding Genor Schedules Board Meeting to Review Interim Results, Consider Dividend

HBM Holdings Secures NMPA Clearance for HBM7004 IND in Advanced Solid Tumors

HBM Gets China NMPA Clearance to Start Hbm7004 Trial in Advanced Solid Tumors

Hbm Holdings - Nmpa Approves Ind Application for Hbm7004 for Advanced Solid Tumors

THOMSON REUTERS

AH Premium Rankings Unveiled: August 18 Market Close Data

Hong Kong Stock Market Flash | Micot Pharma-B (02335) Surges Nearly 6% in Afternoon Session as Innovative Drug XTL6001 Makes Third Appearance on International Academic Stage

Jiangsu Nhwa Pharmaceutical's Innovative Drug NH302 Injection Cleared for Clinical Trials

Hong Kong Stock Spotlight | TYK Medicines-B (02410) Climbs Over 6% in Morning Trade as Half-Year Loss Narrows Sharply and TY-9591 Commercialization Ramps Up

Puqi Pharma's Accumulated Losses Near RMB 400 Million: Net Asset Value Turns Negative, Chief Medical Officer's Compensation Surges

Streamlined Business Environment Boost: Digital Re-Inspection Approval Lets Companies Handle Matters Remotely

Zejing Pharma Seeks Hong Kong Listing After Turning Profitable, But Earnings Quality Raises Questions

TYK Medicines-B Narrows First-Half Loss Significantly as Manufacturing and Commercial Expansion Moves Forward

17 Drugmakers Announce Major Executive Reshuffles in Half a Month

Zai Lab Ltd: Efgartigimod Continues to be Evaluated as a Potential Treatment in Other Autoimmune Rheumatologic Diseases

THOMSON REUTERS

Zai Lab - Phase 3 Study Meets Primary Endpoint of Mean Total Improvement Score at Week 52

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/BK1574/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"Nonprofit Pharmaceutical Companies","latestPrice":496.85574,"timestamp":1787540655639,"preClose":506.0749,"halted":0,"volume":48910124,"delay":0,"changeRate":-0.018217,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":-9.219147,"latestTime":"08-24 11:04:15","open":506.33536,"high":517.53845,"low":496.69476,"amount":1466579785,"amplitude":0.041187,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Noon Closed","tradingStatus":4,"beginTime":1787544000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1787535000000,1787544000000],[1787547600000,1787558400000]],"pbRate":4.109535,"peRate":-81.157718,"turnoverRate":0.001775,"increases":5,"decrements":25,"flats":3,"marketCap":317309804400,"floatMarketCap":282744747560},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":517.53845,"amplitude":0.041187,"preClose":506.0749,"low":496.69476,"pbRate":"4.109535","latestPrice":496.85574,"volume":48910124,"delay":0,"open":506.33536,"prevYearClose":556.26263,"prevWeekClose":506.075,"prevMonthClose":473.313,"prevQuarterClose":453.519,"fiveDayClose":505.128,"twentyDayClose":497.839,"sixtyDayClose":520.536,"secType":"PLATE","market":"HK","turnoverRate":0.001775,"peRate":-81.157718,"marketCap":317309804400,"floatMarketCap":282744747560,"timestamp":1787540655639,"nameCN":"Nonprofit Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":5,"down":25,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660469081","title":"HBM's Cancer Drug Candidate Gets China Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2660469081","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660469081?lang=en_us&edition=fundamental","pubTime":"2026-08-18 18:43","pubTimestamp":1787049788,"startTime":"0","endTime":"0","summary":"HBM Holdings  said China's National Medical Products Administration approved the investigational new drug application for HBM7004, a bispecific antibody candidate for advanced solid tumors.The approval follows U.S. clearance in May to begin a Phase I trial, allowing the company to advance clinical development in both markets, according to a Tuesday Hong Kong bourse filing.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MUU","BK1161","MUD","DRMP","RAM","BK4588","MUZ","MIC","DRMY","DISK","DRAL","MUYY","BK1583","MULL","RAMZ","BK1574","DRAM","HBMX","02142"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175281752","title":"Alphamab's KN026 Combination Therapy for First-Line HER2-Positive Advanced Breast Cancer Receives NMPA Filing Acceptance","url":"https://stock-news.laohu8.com/highlight/detail?id=1175281752","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175281752?lang=en_us&edition=fundamental","pubTime":"2026-08-18 18:06","pubTimestamp":1787047597,"startTime":"0","endTime":"0","summary":"ALPHAMAB-B (09966) has announced that the New Drug Application (NDA) for anitumomab (trade name: Enituo, development code: KN026) in combination with docetaxel injection (albumin-bound) (HB1801) for...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPOS","BK1574","BK1161","09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660466208","title":"Suzhou Basecare Medical Sets Board Meeting to Review Interim Results, Consider Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2660466208","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660466208?lang=en_us&edition=fundamental","pubTime":"2026-08-18 18:05","pubTimestamp":1787047548,"startTime":"0","endTime":"0","summary":"Suzhou Basecare Medical sets board meeting to review interim results, consider dividendSuzhou Basecare Medical will hold a board meeting on Aug. 28, 2026.Interim results for the six months ended June ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDLb0PhCx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02170","BK1574","BK1222","BK1597"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660146646","title":"Alphamab Oncology Says China NMPA Accepts Anbenitamab NDA for First-Line HER2+ Advanced Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2660146646","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660146646?lang=en_us&edition=fundamental","pubTime":"2026-08-18 18:01","pubTimestamp":1787047294,"startTime":"0","endTime":"0","summary":"Alphamab Oncology says China NMPA accepts Anbenitamab NDA for first-line HER2+ advanced breast cancerChina’s NMPA accepted an NDA for anbenitamab (KN026) plus albumin-bound docetaxel HB1801 in first-l","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDL8jzLgj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0008369823.USD","09966","LU1152091754.HKD","LU1226287875.USD","IE00B031HY20.USD","KURE","LU1008478684.HKD","LU1152091168.USD","IE00BZ08YS42.EUR","LU1951186391.HKD","SG9999004220.SGD","LU0072913022.USD","LU1960683339.HKD","LU0501845795.SGD","LU1813983027.USD","LU1993786604.SGD","LU0315179316.USD","HK0000165453.HKD","BK1191","LU0880133367.SGD","IE00BZ08YR35.GBP","LU1226287792.SGD","LU1807302812.USD","IE00BZ08YT58.USD","BK1515","LU1226288253.USD","LU0314109678.HKD","LU1226288170.HKD","LU2039709279.SGD","LU1226287529.USD","LU1328277881.USD","IE00B5MMRT66.SGD","01093","LU0067412154.USD","BK1574","IE0008368742.USD","IE00B543WZ88.USD","BK1161","BK1521","LU0140636845.USD","LU0326950275.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660466130","title":"Alphamab Oncology - Nmpa Accepts Nda for Anbenitamab (Kn026) with Hb1801 for Her2+ Advanced Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2660466130","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660466130?lang=en_us&edition=fundamental","pubTime":"2026-08-18 18:00","pubTimestamp":1787047230,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nFWN44F0FD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","BK1161","09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660658484","title":"Edding Genor Schedules Board Meeting to Review Interim Results, Consider Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2660658484","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660658484?lang=en_us&edition=fundamental","pubTime":"2026-08-18 17:19","pubTimestamp":1787044796,"startTime":"0","endTime":"0","summary":"Edding Genor schedules board meeting to review interim results, consider dividendBoard meeting set for Aug. 28, 2026 to review interim results for the six months ended June 30, 2026.Directors will als","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDL8s1kkf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1574","BK1583","06998"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198403419","title":"HBM Holdings Secures NMPA Clearance for HBM7004 IND in Advanced Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=1198403419","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198403419?lang=en_us&edition=fundamental","pubTime":"2026-08-18 17:09","pubTimestamp":1787044155,"startTime":"0","endTime":"0","summary":"HBM Holdings-B (02142) has announced that its Investigational New Drug (IND) application for HBM7004, a novel B7H4xCD3 bispecific antibody designed for advanced solid tumors, has been approved by...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","IBBJ","BMED","MDTX","BK1161","02142","IBBQ","PSYK","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660463171","title":"HBM Gets China NMPA Clearance to Start Hbm7004 Trial in Advanced Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2660463171","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660463171?lang=en_us&edition=fundamental","pubTime":"2026-08-18 17:02","pubTimestamp":1787043736,"startTime":"0","endTime":"0","summary":"HBM gets China NMPA clearance to start HBM7004 trial in advanced solid tumorsChina’s drug regulator cleared HBM Holdings’ IND for HBM7004 in advanced solid tumors, enabling a China Phase 1 first-in-human study.HBM7004 is a B7H4xCD3 bispecific antibody developed on the HBICE platform.The clearance follows earlier FDA authorization to start a Phase 1 trial in the US.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HBM Holdings Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on August 18, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDLbdTbRw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1583","02142","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660163463","title":"Hbm Holdings - Nmpa Approves Ind Application for Hbm7004 for Advanced Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2660163463","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660163463?lang=en_us&edition=fundamental","pubTime":"2026-08-18 17:01","pubTimestamp":1787043663,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nFWN44F018:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1583","BK1161","BK1574","02142"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162248813","title":"AH Premium Rankings Unveiled: August 18 Market Close Data","url":"https://stock-news.laohu8.com/highlight/detail?id=1162248813","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162248813?lang=en_us&edition=fundamental","pubTime":"2026-08-18 16:21","pubTimestamp":1787041299,"startTime":"0","endTime":"0","summary":"As of the market close on August 18, data from Zhitong Finance reveals that NE ELECTRIC (00042), ZHEJIANG SHIBAO (01057), and SINOPEC SSC (01033) hold the top three positions in the A-H share premium...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1193","IE00BVYPNQ40.USD","BK1209","LU0348814723.USD","02846","LU0620787316.HKD","LU0737861699.HKD","LU0516422440.USD","LU1675838814.USD","IE00B031J352.USD","LU0455707207.USD","LU2008162690.USD","LU0327786744.USD","LU0871576103.HKD","LU0648948544.HKD","LU2226246903.HKD","LU1769817179.HKD","LU0828237940.HKD","LU0329678170.USD","BK1576","LU0328353924.USD","02050","BK1183","HK0000320264.USD","SG9999011746.SGD","SGXZ49509284.SGD","02218","LU1282648689.USD","BK1161","LU2476274720.SGD","BK1198","LU1769817096.USD","LU0039217434.USD","BK1141","LU0164865239.USD","BK1594","BK1607","LU1688375341.USD","LU0128522157.USD","03130","LU1328277881.USD","LU1244550494.USD","SG9999002828.SGD","EWH","LU0106252389.USD","BK1149","LU1046422090.SGD","06655","03328","LU0880133367.SGD","BK1610","LU1282649141.HKD","02359","BK1135","02865","LU0791591158.USD","LU1282649810.SGD","LU2125910500.SGD","BK1186","LU0359201885.HKD","BK1614","BK1163","SG9999001093.SGD","IE00BMCWC346.EUR","LU0456827905.SGD","LU0501845795.SGD","BK1214","LU1504937902.USD","IE00B29SXG58.USD","02691","BK1171","SG9999001226.SGD","LU0543330566.HKD","LU1251922891.USD","LU0149721374.USD","LU0918141887.USD","LU0886674414.USD","LU0431992006.USD","LU1152091168.USD","LU0072913022.USD","LU0029875118.USD","HK0000306685.HKD","LU0348827113.USD","LU0572944931.SGD","LU0640798160.USD","BK1574","LU0561508036.HKD","LU0791590937.USD","01989","03200","LU0210526637.USD","159982","BK1554","LU0348805143.USD","LU0163747925.USD","BK1505","LU1988902786.USD","LU1770034418.SGD","LU0096374516.USD","BK1551","LU0417516738.SGD","LU2148510915.USD","LU1831875114.USD","LU2778985437.USD","LU2264538146.SGD","LU2097828474.EUR","LU0320764755.SGD","LU0516423174.USD","BK1521","LU0307460666.USD","BK1122","LU1211504680.USD","LU0266512127.USD","00187","LU0043850808.USD","LU0231483743.USD","IE0031814852.USD","IE00B3M56506.USD","LU0531971595.HKD","LU1064130708.USD","BK1507","LU0348766576.USD","BK1240","BK1105","BK1560","LU0149534421.HKD","07233","LU0229945570.USD","LU0463099449.HKD","LU0737861772.HKD","LU2399975544.HKD","LU0228659784.USD","LU0589944569.HKD","82846","01033","LU0082770016.SGD","LU1366334578.USD","LU0082770016.USD","LU0244354667.USD","IE00BGHQDM52.EUR","LU1282649067.USD","LU0345780281.USD","688981","02899","BK1514","01108","SG9999004220.SGD","LU1242518857.USD","LU1808992512.USD","LU2476274308.USD","BK1202","LU0469268626.HKD","BK1190","03750","LU0117841782.USD","03308","HK0000306701.USD","LU0314109678.HKD","LU0348767384.USD","LU1880383440.USD","LU0051755006.USD","LU1794554557.SGD","IE00BVYPNP33.GBP","LU2097828805.USD","BK1147","HK0000352382.USD","LU0672654166.SGD","LU0708995583.HKD","BK1515","LU0326950275.SGD","LU0254981946.USD","HK0000320223.HKD","01349","LU0540923850.HKD","LU2294711473.HKD","BK1237","LU0348735423.USD","LU0821914370.USD","LU2039709279.SGD","03143","LU1224709979.USD","LU0531970944.HKD","LU0868486357.SGD","03188","LU0516423091.SGD","LU0488056044.USD","LU0165289439.USD","06951","BK1170","LU0214875030.USD","LU0164939612.USD","IE0034224299.USD","LU0348788117.USD","LU1115378108.SGD","LU0359202008.SGD","BK1592","LU0320764599.SGD","LU0052750758.USD","LU1064131342.USD","LU1188198961.HKD","HK0001040143.USD","SGXZ81163826.USD","02475","LU0509642566.USD","LU0048580855.USD","LU0979878070.USD","00981","LU0140636845.USD","LU0516422366.SGD","BK1191","SG9999014674.SGD","02338","LU0345780521.USD","LU0456854461.SGD","BK1526","IE00BZ08YS42.EUR","06185","IE00B5MMRT66.SGD","LU1008478684.HKD","HK0000352291.HKD","00042","00568","LU1720050803.USD","LU0384037296.USD","LU2097828631.EUR","02827","LU1807302812.USD","LU0370786039.SGD","BK1223","01057","LU0823426480.USD","LU0823426308.USD","06869","IE00BZ08YR35.GBP","03678","IE0008369823.USD","LU2097828557.USD","LU1960683339.HKD","LU0588546209.SGD","LU0634319403.HKD","LU0266512473.USD","LU1064131003.USD","BK1506","LU1105468828.SGD","LU0797268264.HKD","03986","LU2177674079.SGD","IE0032431581.USD","BK1546","06166","06745","BK1562","LU0417516902.SGD","LU0502904849.HKD","IE00B543WZ88.USD","LU0061477393.USD","IE0008368742.USD","LU3063872942.SGD","03968","LU0607220059.USD","LU1242518931.SGD","IE00BF5LJ272.USD","00553","LU0359201612.USD","LU0181495838.USD","LU0543330483.HKD","LU1244550577.SGD","83130","LU1961090484.USD","BK1544","LU0516422952.EUR","LU0918141705.HKD","LU0315179316.USD","00300","LU0828238088.HKD","LU0049853897.USD","IE00B0169L03.USD","IE00B031HY20.USD","LU0269904917.USD","LU1719994722.HKD","BK1564","BK1231","LU0329678337.USD","LU1366334651.USD","SG9999002463.SGD","IE00BYV24P56.USD","LU0348816934.USD","BK1533","BK1522","LU0211977185.USD","LU2242644610.SGD","399300","BK0214","LU0593848301.USD","01812","LU0228367735.SGD","LU1993786604.SGD","LU1303224171.USD","LU1152091754.HKD","IE00BZ08YT58.USD","LU0348825331.USD","LU0890818403.SGD","LU2097828714.EUR","LU1048596156.SGD","83188","LU0287142896.SGD","LU1813983027.USD","SG9999006597.SGD","06613","LU0106959298.USD","BK1249","LU1481107354.HKD","BK1523","LU0862451753.SGD","LU1023057109.AUD","LU0164880469.USD","LU1244550221.USD","BK1110","LU1880383366.USD","LU0449509016.USD","LU0828237510.HKD","LU2045819591.USD","LU1226287529.USD","BK1116","00668","HK0001040168.HKD","BK1144","LU0067412154.USD","BK1583","LU0456846285.SGD","LU0173614495.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176624055","title":"Hong Kong Stock Market Flash | Micot Pharma-B (02335) Surges Nearly 6% in Afternoon Session as Innovative Drug XTL6001 Makes Third Appearance on International Academic Stage","url":"https://stock-news.laohu8.com/highlight/detail?id=1176624055","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176624055?lang=en_us&edition=fundamental","pubTime":"2026-08-18 13:50","pubTimestamp":1787032215,"startTime":"0","endTime":"0","summary":"MICOT PHARMA-B (02335) jumped nearly 6% in the afternoon session, trading up 5.94% at HK$32.12 with turnover reaching HK$12.68 million at the time of writing.On the news front, the company's...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXUS","BK4588","BK1574","BK4585","159992","MEDX","KCAI","06978","LNGR","IBBQ","BK1161","02335"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116946341","title":"Jiangsu Nhwa Pharmaceutical's Innovative Drug NH302 Injection Cleared for Clinical Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=1116946341","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116946341?lang=en_us&edition=fundamental","pubTime":"2026-08-18 12:00","pubTimestamp":1787025628,"startTime":"0","endTime":"0","summary":"Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262.SZ) has announced that it recently received the Drug Clinical Trial Approval Notice issued by the National Medical Products Administration for its Class...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1064130708.USD","LU2148510915.USD","159992","IBBQ","MDTX","BK1574","PSYK","BMED","06978","002262","BK1161","BK0239","MEDX","LNGR","IBBJ","BK0188","LU1064131003.USD","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161497517","title":"Hong Kong Stock Spotlight | TYK Medicines-B (02410) Climbs Over 6% in Morning Trade as Half-Year Loss Narrows Sharply and TY-9591 Commercialization Ramps Up","url":"https://stock-news.laohu8.com/highlight/detail?id=1161497517","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161497517?lang=en_us&edition=fundamental","pubTime":"2026-08-18 11:11","pubTimestamp":1787022675,"startTime":"0","endTime":"0","summary":"TYK Medicines-B (02410) saw its share price rally more than 6% during the morning session, last trading 5.63% higher at HK$7.13 with turnover reaching HK$16.15 million.The company's interim results...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1574","BK1161","BK4585","09939","02410","BK4588","KCAI","TY","VXUS","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137276197","title":"Puqi Pharma's Accumulated Losses Near RMB 400 Million: Net Asset Value Turns Negative, Chief Medical Officer's Compensation Surges","url":"https://stock-news.laohu8.com/highlight/detail?id=1137276197","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137276197?lang=en_us&edition=fundamental","pubTime":"2026-08-18 09:51","pubTimestamp":1787017865,"startTime":"0","endTime":"0","summary":"From its New Third Board listing, to a withdrawn Beijing Stock Exchange application, and then two consecutive Hong Kong IPO filings, the capital market journey of Beijing Puqi Pharmaceutical...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","159891","159938","BK1515","09939","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182114698","title":"Streamlined Business Environment Boost: Digital Re-Inspection Approval Lets Companies Handle Matters Remotely","url":"https://stock-news.laohu8.com/highlight/detail?id=1182114698","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182114698?lang=en_us&edition=fundamental","pubTime":"2026-08-18 07:40","pubTimestamp":1787010033,"startTime":"0","endTime":"0","summary":"A medical device logistics firm in Cangzhou Economic Development Zone has become an early beneficiary of a new digital service that eliminates the need for physical visits during approval...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LGHT","RSPH","09996","LNGR","MEDX","BK1100","BK1574","GDOC","AGNG","HART","MDEV","PTH","IEIH","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164031025","title":"Zejing Pharma Seeks Hong Kong Listing After Turning Profitable, But Earnings Quality Raises Questions","url":"https://stock-news.laohu8.com/highlight/detail?id=1164031025","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164031025?lang=en_us&edition=fundamental","pubTime":"2026-08-17 22:50","pubTimestamp":1786978246,"startTime":"0","endTime":"0","summary":"Zejing Pharma (688266.SH) restarted its Hong Kong IPO on August 12, with China International Capital Corporation serving as the sole sponsor, marking the company's second attempt at the HKEX Chapter...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IPOS","01477","KCAI","BK1574","BK1191","BK4585","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181695401","title":"TYK Medicines-B Narrows First-Half Loss Significantly as Manufacturing and Commercial Expansion Moves Forward","url":"https://stock-news.laohu8.com/highlight/detail?id=1181695401","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181695401?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:49","pubTimestamp":1786970980,"startTime":"0","endTime":"0","summary":"TYK MEDICINES-B (02410) has reported its interim results for the 2026 fiscal year, revealing a substantial improvement in its financial performance. Research and development costs reached RMB 94.943...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410","BK1574","BK1515","09939","159938","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172473486","title":"17 Drugmakers Announce Major Executive Reshuffles in Half a Month","url":"https://stock-news.laohu8.com/highlight/detail?id=1172473486","media":"Deep News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172473486?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:23","pubTimestamp":1786969423,"startTime":"0","endTime":"0","summary":"August is only half over, yet at least 17 pharmaceutical companies have already announced senior executive changes, spanning key roles such as board chairmen, general managers, and CEOs. These...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01477","BK1191","01952","BK1161","BK1574","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660899374","title":"Zai Lab Ltd: Efgartigimod Continues to be Evaluated as a Potential Treatment in Other Autoimmune Rheumatologic Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2660899374","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660899374?lang=en_us&edition=fundamental","pubTime":"2026-08-17 18:00","pubTimestamp":1786960800,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nTUABNJQ3X:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["09688","BK1588","BK1574","LU2488822045.USD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660896554","title":"Zai Lab - Phase 3 Study Meets Primary Endpoint of Mean Total Improvement Score at Week 52","url":"https://stock-news.laohu8.com/highlight/detail?id=2660896554","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660896554?lang=en_us&edition=fundamental","pubTime":"2026-08-17 18:00","pubTimestamp":1786960800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nTUABNJQ3X:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2488822045.USD","BK1588","BK1161","09688","BK1574"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":15,"pageCount":8,"totalSize":285,"code":"91000000","status":"200"}]}}